| |
Total (N = 15,992)
|
Africa (n = 812)
|
Americas (n = 2002)
|
South-East Asia (n = 3360)
|
Europe (n = 3479)
|
Eastern Mediterranean (n = 2182)
|
Western Pacific (n = 4157)
|
|---|
|
Any microvascular disease, n (%)
|
3005 (18.8)
|
118 (14.5)
|
302 (15.1)
|
556 (16.5)
|
812 (23.5)
|
399 (18.3)
|
818 (19.7)
|
|
CKD
|
794 (5.0)
|
20 (2.5)
|
90 (4.5)
|
23 (0.7)
|
257 (7.4)
|
31 (1.4)
|
373 (9.0)
|
|
Albuminuria
|
605 (4.3)
|
21 (2.6)
|
40 (2.0)
|
188 (5.6)
|
195 (5.6)
|
91 (4.2)
|
70 (3.1)
|
|
Retinopathy
|
624 (3.9)
|
22 (2.7)
|
68 (3.4)
|
30 (0.9)
|
198 (5.7)
|
69 (3.2)
|
237 (5.7)
|
|
Retinal laser photocoagulation
|
98 (0.6)
|
4 (0.5)
|
17 (0.8)
|
1 (0.0)
|
14 (0.4)
|
9 (0.4)
|
53 (1.3)
|
|
Autonomic neuropathy
|
155 (1.0)
|
1 (0.1)
|
9 (0.4)
|
40 (1.2)
|
28 (0.8)
|
25 (1.1)
|
52 (1.3)
|
|
Peripheral neuropathy
|
1237 (7.7)
|
47 (5.8)
|
114 (5.7)
|
324 (9.6)
|
324 (9.4)
|
181 (8.3)
|
247 (5.9)
|
|
Erectile dysfunction
|
426 (2.7)
|
38 (4.7)
|
65 (3.2)
|
28 (0.8)
|
115 (3.3)
|
102 (4.7)
|
78 (1.9)
|
|
Any macrovascular disease, n (%)
|
2027 (12.7)
|
74 (9.1)
|
232 (11.6)
|
135 (4.0)
|
915 (26.7)
|
218 (10.0)
|
453 (10.9)
|
|
Heart failure
|
527 (3.3)
|
7 (0.9)
|
54 (2.7)
|
18 (0.5)
|
368 (10.7)
|
23 (1.1)
|
57 (1.4)
|
|
CAD
|
1310 (8.2)
|
59 (7.3)
|
151 (7.5)
|
91 (2.7)
|
622 (18.1)
|
172 (7.9)
|
215 (5.2)
|
|
Angina
|
473 (3.0)
|
19 (2.3)
|
53 (2.6)
|
10 (0.3)
|
262 (7.6)
|
40 (1.8)
|
89 (2.1)
|
|
Myocardial infarction
|
445 (2.8)
|
39 (4.8)
|
80 (4.0)
|
18 (0.5)
|
228 (6.6)
|
31 (1.4)
|
49 (1.2)
|
|
PCI
|
424 (2.7)
|
10 (1.2)
|
62 (3.1)
|
19 (0.6)
|
184 (5.4)
|
70 (3.2)
|
79 (1.9)
|
|
CABG
|
140 (0.9)
|
10 (1.2)
|
17 (0.8)
|
13 (0.4)
|
71 (2.1)
|
15 (0.7)
|
14 (0.3)
|
|
Stroke
|
352 (2.2)
|
4 (0.5)
|
35 (1.7)
|
20 (0.6)
|
114 (3.3)
|
29 (1.3)
|
150 (3.6)
|
|
Transient ischemic attack
|
107 (0.7)
|
3 (0.4)
|
14 (0.7)
|
1 (0.0)
|
36 (1.0)
|
17 (0.8)
|
36 (0.9)
|
|
Carotid artery stent
|
16 (0.1)
|
0 (0.0)
|
1 (0.0)
|
0 (0.0)
|
7 (0.2)
|
4 (0.2)
|
4 (0.1)
|
|
Carotid endarterectomy
|
16 (0.1)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
12 (0.3)
|
1 (0.0)
|
3 (0.1)
|
|
PAD
|
197 (1.2)
|
4 (0.5)
|
15 (0.7)
|
2 (0.1)
|
108 (3.1)
|
10 (0.5)
|
58 (1.4)
|
|
Diabetic foot
|
87 (0.5)
|
4 (0.5)
|
20 (1.0)
|
15 (0.4)
|
32 (0.9)
|
7 (0.3)
|
9 (0.2)
|
|
Amputation
|
32 (0.2)
|
6 (0.7)
|
12 (0.6)
|
1 (0.0)
|
9 (0.3)
|
3 (0.1)
|
1 (0.0)
|
|
Defibrillator use
|
8 (0.1)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
7 (0.2)
|
0 (0.0)
|
1 (0.0)
|
- Percentages calculated for all patients with data available; unreported data are excluded
- CABG coronary artery bypass grafting, CAD coronary artery disease, CKD chronic kidney disease, PAD peripheral artery disease, PCI percutaneous coronary intervention
